Zoetis at a Glance
![corporate brochure](http://www.zoetis.com/_locale-assets/img/corporate-brochure/zoetis-core-species-ad.jpg)
Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals in more than 100 countries.
Here is Zoetis at a glance:
![Zoetis At A Glance Infographic](http://www.zoetis.com/_locale-assets/img/about-us/at-a-glance/zoetis-at-a-glance.jpg)
65+
Our years of experience in animal health
100+
Countries in which Zoetis products are sold
11,300
Approximate number of Zoetis colleagues
$6.7 billion
Annual revenue (2020)
44%
Revenue from farm animal products
55%
Revenue from companion animal products
8
Species supported by Zoetis — cattle (beef and dairy), swine, poultry, sheep, fish, dogs, cats and horses
7
• 7 product categories: vaccines, anti-infectives, parasiticides, dermatology products, medicated feed additives, animal health diagnostics, other pharmaceuticals
300
Number of Product lines
29
Number of Zoetis manufacturing sites — all dedicated to delivering a reliable supply of quality products
1,250
Approximate number of R&D Colleagues
3,600
Approximate number of field force members